Filter

181 - 190 of 792 Results

  • Pharmacy Plus Waivers: Trade Offs Between Expanding Rx Coverage and Global Caps in Medicaid

    Issue Brief

    The Kaiser Commission on Medicaid and the Uninsured has been monitoring the development of the Pharmacy Plus waiver initiated by the Bush Administration in 2002 and tracking the states that have pending or approved plans. The Commission has developed some materials describing the initiative, examining the financing mechanism, and discussing the implications for the Medicaid program and participating states. The Pharmacy Plus initiative allows states to secure federal Medicaid matching funds for prescription programs for…

  • The Development of Direct-to-Consumer Prescription Drug Advertising Regulation

    Other Post

    This article, which appears in the Food and Drug Law Journal, vol. 57, no. 3, 2002, pp. 423-444 was based on a report written by F.B. Palumbo and C.D. Mullins at the University of Maryland School of Pharmacy Center on Drugs and Public Policy and funded by the Kaiser Family Foundation. The article provides an historical overview and current U.S. Food and Drug Administration regulation of advertising prescription drugs directly to consumers. The article also…

  • Understanding the Health-Care Needs and Experiences of People with Disabilities:  Findings from a 2003 Survey

    Report

    Understanding the Health-Care Needs and Experiences of People with Disabilities: Findings from a 2003 Survey People with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people with permanent mental and/or physical disabilities explores their health-care experiences and challenges in accessing and paying for care. Report (.pdf) Chartpack, video, press release,…

  • Policy Workshop on Formularies and Medicare

    Event Date:
    Event

    The Kaiser Family Foundation hosted a March 14, 2005 policy workshop on the use of drug formularies in the private sector and their potential implications for beneficiaries under the new Medicare drug benefit, set to go into effect January 1, 2006. The workshop involved an expert panel, including perspectives from a health plan, a pharmacy benefits manager, a physician, the Centers for Medicare & Medicaid Services and policy experts. Agenda (.pdf) Presentation (.pdf) Speaker Biographies…

  • Medicare Part D Issue Briefs

    Issue Brief

    These issue briefs, prepared by the Centers for Medicare Advocacy, Inc., provide information about how the Medicare drug benefit will affect beneficiaries. The briefs address issues related to dual eligibles, residents of nursing home and assisted living facilities, and the Part D exceptions and appeals processes. Medicare Part D: Issues for Dual Eligibles on the Eve of Implementation Medicare Prescription Drug Coverage for Residents of Nursing Homes and Assisted Living Facilities: Special Problems and Concerns…

  • Medicare Part D 2010 Data Spotlights

    Issue Brief

    The Kaiser Family Foundation has issued a collection of analyses related to the Part D Medicare stand-alone drug plan options available to seniors for calendar year 2010. Each of these spotlights focuses on a key aspect of the drug plans that will be available to Medicare beneficiaries in 2010 and examine relevant trends since the Medicare drug benefit took effect in 2006. They were prepared by a team of researchers at Georgetown University, NORC and…

  • New Reports Explore State Implementation of Prescription Drug Prior Authorization

    Other Post

    States are grappling with a fiscal crisis that threatens funding for Medicaid, the federal-state partnership that provides health coverage for low-income populations. Two new studies shed light on the impact of an increasingly popular strategy - prior authorization - being used to control prescription drug spending. In fiscal year 2003, some 21 states are planning to expand or create prior authorization systems where the state must provide pre-approval before selected drugs can be dispensed to…

  • Selected Findings on Knowledge and Understanding of the New Medicare Rx Drug Program — January/February 2004 Kaiser Health Poll Report Survey

    Poll Finding

    Seniors are confused about the Medicare prescription drug law. Selected findings from the January/February 2004 Kaiser Health Poll Report survey show that while about two-thirds of seniors report following the debate closely, just 15% say they understand the new prescription drug law very well and seven in 10 don’t know that it passed and was signed into law. Survey Toplines Chartpack News Release Statement by Drew Altman, President and CEO, Kaiser Family Foundation on the…

  • How Much is Health Spending Expected to Grow?

    Feature

    This chart collection explores how health spending is expected to grow in coming years, with a look at growth in prescription drug spending, out-of-pocket spending, and related trends.